Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
Francisco Garcia Parames Reduces Stake in Atalaya Mining Copper SA by 42.93%
06:03pm, Wednesday, 04'th Feb 2026
Exploring the Strategic Moves of a Renowned Value Investor Francisco Garcia Parames (Trades, Portfolio), a prominent figure in the world of value investing, re
Teva Pharmaceutical Industries (NYSE:TEVA) Reaches New 12-Month High Following Earnings Beat
01:22am, Friday, 30'th Jan 2026
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA - Get Free Report)'s stock price reached a new 52-week high on Thursday after the company announced better than expected quarterly earnings. The company
TEVA's Q4 Earnings Beat, Branded Drugs Drive Revenue Growth
12:26pm, Thursday, 29'th Jan 2026
Teva beats Q4 estimates driven by a Sanofi milestone and strong Austedo growth. The drugmaker also unveils its 2026 outlook.
Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript
02:02pm, Wednesday, 28'th Jan 2026
Teva Pharmaceutical Industries Limited (TEVA) Q4 2025 Earnings Call Transcript
Teva's Flagship Drugs Hit $1 Billion Milestone, Raises Confidence In 2026 Outlook
12:22pm, Wednesday, 28'th Jan 2026
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) reported its fourth-quarter 2025 financial results on Wednesday, with total revenue of $4.71 billion, beating analysts' expectations of $4.37 billion,
Here's Why Teva Pharmaceutical Industries Ltd. (TEVA) is a Strong Value Stock
10:40am, Wednesday, 28'th Jan 2026
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Teva Pharmaceutical Industries (TEVA) Reports Q4 Earnings: What Key Metrics Have to Say
10:31am, Wednesday, 28'th Jan 2026
The headline numbers for Teva Pharmaceutical Industries (TEVA) give insight into how the company performed in the quarter ended December 2025, but it may be worthwhile to compare some of its key metri
Teva Pharmaceutical profit, revenue rise in fourth quarter
07:31am, Wednesday, 28'th Jan 2026
Teva Pharmaceutical Industries reported on Wednesday a higher-than-expected rise in fourth-quarter profit, boosted by sales of its branded drugs as well as a milestone payment to begin a late stage st
Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in U.S. dollars, or 3% in local currency (LC) terms, compared to 2024. Excluding Ja
Will Forte Teams Up with Teva to Get Real About Huntington's Disease with ‘Honestly HD'
08:00am, Tuesday, 27'th Jan 2026
PARSIPPANY, N.J., and TEL AVIV, Israel, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced a partner
Strs Ohio Lowers Holdings in Teva Pharmaceutical Industries Ltd. $TEVA
06:44am, Monday, 26'th Jan 2026
Strs Ohio reduced its position in Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) by 3.3% during the undefined quarter, according to its most recent filing with the SEC. The firm owned 762,907 shares
Rakuten Investment Management Inc. Makes New $437,000 Investment in Teva Pharmaceutical Industries Ltd. $TEVA
05:51am, Monday, 26'th Jan 2026
Rakuten Investment Management Inc. bought a new stake in shares of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) in the third quarter, according to the company in its most recent disclosure with th
What Analyst Projections for Key Metrics Reveal About Teva Pharmaceutical Industries (TEVA) Q4 Earnings
10:15am, Friday, 23'rd Jan 2026
Get a deeper insight into the potential performance of Teva Pharmaceutical Industries (TEVA) for the quarter ended December 2025 by going beyond Wall Street's top-and-bottom-line estimates and examini
FINANCIAL CONSULATE, INC Buys 270 Shares of Teva Pharmaceutical Industries Ltd (TEVA)
09:13am, Thursday, 22'nd Jan 2026
Summary FINANCIAL CONSULATE, INC raised its stake in Teva Pharmaceutical Industries Ltd (TEVA) by 310.34%, purchasing 270 shares to own 357 shares valu
ANIP vs. TEVA: Which Drug Stock Is the Better Buy Right Now?
09:56am, Friday, 16'th Jan 2026
ANI Pharmaceuticals' rare disease growth, led by surging Cortrophin Gel sales, is outpacing Teva's slower sales momentum in this head-to-head stock comparison.
